The impact of birth weight on prostate cancer incidence and mortality in a population-based study of men born in 1913 and followed up from 50 to 85 years of age

Prostate

Volumn 67, Issue 11, 2007, Pages 1247-1254

  Eriksson, Margaretha ^a   Wedel, Hans ^b   Wallander, Mari Ann ^a,c   Krakau, Ingvar ^d   Hugosson, Jonas ^e   Carlsson, Sture ^f   Svärdsudd, Kurt ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b NORDIC SCHOOL OF PUBLIC HEALTH   (Sweden)

^c ASTRAZENECA R AND D   (Sweden)

^d KAROLINSKA INSTITUTE   (Sweden)

^e UNIVERSITY OF GOTHENBURG   (Sweden)

^f Department of Anaesthesiology and Intensive Care   (Sweden)

Author keywords

Birth weight; Cohort studies; Follow up studies; Prostate cancer

Indexed keywords

SOMATOMEDIN C;

ADULT; AGED; ARTICLE; BIRTH WEIGHT; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; COHORT ANALYSIS; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; PROSTATE CANCER; SWEDEN;

AGED; AGED, 80 AND OVER; BIRTH WEIGHT; COHORT STUDIES; FOLLOW-UP STUDIES; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; SWEDEN;

EID: 34547652260     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.20428     Document Type: Article

References (58)

1. Grönberg H. Prostate cancer epidemiology. Lancet 2003;361:859-864.
2. Hugosson J, Aus G, Becker C, Carlsson S, Eriksson H, Lilja H, Lodding P, Tibblin G. Would prostate cancer detected by screening with prostate-specific antigen develop into clinical cancer if left undiagnosed? A comparison of two population-based studies in Sweden. BJU Int 2000;85:1078-1084.
3. Dillner K. Molecular characterization of prostate hyperplasia in prolactin transgenic mice. Göteborg University [MD], 2003.
4. Trichopoulos D, Lipworth L. Is cancer causation simpler than we thought, but more intractable? Epidemiology 1995;6:347-349.
5. Tibblin G, Eriksson M, Cnattingius S, Ekbom A. High birth weight as a predictor of prostate cancer risk. Epidemiology 1995;6:423-424.
6. López-Otín C, Diamandis EP. Breast and prostate cancer: An analysis of common epidemiological, genetic, and biochemical features. Endocrine Rev 1998;19:365-396.
7. Ekbom A. Growing evidence that several human cancers may originate in utero. Semin Cancer Biol 1998;8:237-244.
8. Skalkidou A, Petridou E, Papathom E, Salvanos H, Chrousos G, Thichopoulos D. Birth size and neonatal levels of major components of the IGF system: Implications for later risk of cancer. J Pediatr Endocrinol Metabol 2002;15:1479-1486.
9. Ekbom A, Trichopoulos D, Adami HO, Hsieh CC, Lan SJ. Evidence of prenatal influences on breast cancer risk. Lancet 1992;340:1015-1018.
10. McCormack VA, dos Santos Silva I, De Stavola BL, Mohsen R, Leon DA, Lithell HO. Fetal growth and subsequent risk of breast cancer: Results from long term follow up of Swedish cohort. BMJ 2003;326:248.
11. McCormack VA, dos Santos Silva I, Koupil I, Leon DA, Lithell HO. Birth characteristics and adult cancer incidence: Swedish cohort of over 11,000 men and women. Int J Cancer 2005;115:611-617.
12. Vatten LJ, Nilsen TIL, Tretli S, Trichopoulos D, Romundstad PR. Size at birth and risk of breast cancer: Prospective population-based study. Int J Cancer 2005;114:461-464.
13. Henderson BE, Ross RK, Pike MC, Casagrande JT. Endogenous hormones as a major factor in human cancer. Cancer Res 1982;42:3232-3239.
14. Nilsen TIL, Romundstad PR, Troisi R, Vatten LJ. Birth size and subsequent risk for prostate cancer: A prospective population-based study in Norway. Int J Cancer 2005;113:1002-1004.
15. Ross RK, Henderson BE. Do diet and androgens alter prostate cancer risk via a common etiologic pathway? J Natl Cancer Inst 1994;86:252-254.
16. Holly JMP, Gunnell DJ, Davey Smith G. Growth hormone, IGF-I and cancer: Less intervention to avoid cancer? More intervention to prevent cancer? J Endocrinol 1999;162:321-330.
17. Gunnell D. Height, insulin-like growth factors and cancer risk. Growth Horm IGF Res 2000;10(suppl A):S39-S40.
18. Davey Smith G, Gunnell D, Holly J. Cancer and insulin-like growth factor-I: A potential mechanism linking the environment with cancer risk. BMJ 2000;321:847-848.
19. Gunnell D, Okasha M, Davey Smith G, Oliver SE, Sandhu J, Holly JMP. Height, leg length, and cancer risk: A systematic review. Epidemiol Rev 2001;23:313-342.
20. Skalkidou A, Petridou E, Papathoma E, Salvanos H, Kedikoglou S, Chrousos G, Trichopoulos D. Determinants and consequences of major insulin-like growth factors components among full-term health neonates. Cancer Epidemiol Biomarkers Prev 2003;12:860-865.
21. Christou H, Connors JM, Ziotopoulou M, Hatzidakis V, Papathanassoglou E, Ringer SA, Mantzoros CS. Cord blood leptin and insulin-like growth factor levels are independent predictors of fetal growth. J Clin Endocrinol Metab 2001;86:935-938.
22. Ochoa R, Zarate A, Hernandez M, Galvan R, Basurto L. Serum leptin and somatotropin components correlate with neonatal birth weight. Gynecol Obstet Invest 2001;52:243-247.
23. Vatten LJ, Odegard RA, Nilsen ST, Salvesen KA, Austgulen R. Relationship of insulin-like growth factor-I and insulin-like growth factor binding proteins in umbilical cord plasma to preeclampsia and infant birth weight. Obstet Gynecol 2002;99:85-90.
24. Mantzoros CS, Tzonou A, Signorello LB, Stampfer M, Trichopoulos D, Adami HO. Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia. Br J Cancer 1997;76:1115-1118.
25. Chan JM, Stampfer MJ, Giovannucci E, Gann PH, Ma J, Wilkinson P, Hennekens CH, Pollak M. Plasma insulin-like growth factor-I and prostate cancer risk: A prospective study. Science 1998;279:563-566.
26. Wolk A, Mantzoros CS, Andersson SO, Bergström R, Signorello LB, Lagiou P, Adami HO, Trichopoulos D. Insulin-like growth factor 1 and prostate cancer risk: A population-based, case-control study. J Natl Cancer Inst 1998;90:911-915.
27. Stattin P, Bylund A, Rinaldi S, Biessy C, Déchaud H, Stenman UH, Egevad L, Riboli E, Hallmans G, Kaaks R. Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: A prospective study. J Natl Cancer 2000;92:1910-1917.
28. Fall CH, Pandit AN, Law CM, Yajnik CS, Clark PM, Breier B, Osmond C, Shiell AW, Gluckman PD, Barker DJ. Size at birth and plasma insulin-like growth factor-1 concentrations. Arch Dis Child 1995;73:287-293.
29. Fall CHD, Clark PM, Hindmarsh PC, Clayton PE, Shiell AW, Law CM. Urinary GH and IGF-I excretion in nine year-old children: Relation to sex, current size and size at birth. Clin Endocrinol 2000;53:69-76.
30. Juul A, Bang P, Hertel NT, Main K, Dalgaard P, Jørgensen K, Müller J, Hall K, Skakkebæk NE. Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: Relation to age, sex, stage of puberty, testicular size, and body mass index. J Clin Endocrinol Metab 1994;78:744-752.
31. Gunnell DJ, Davey Smith G, Frankel S, Nanchahal K, Braddon FEM, Pemberton J, Peters TJ. Childhood leg length and adult mortality: Follow up of the Carnegie (Boyd Orr) survey of diet and health in pre-war Britain. J Epidemiol Community Health 1998;52:142-152.
32. Frankel S, Gunnell DJ, Peters TJ, Maynard M, Davey Smith G. Childhood energy intake and adult mortality from cancer: The Boyd Orr cohort study. BMJ 1998;316:499-504.
33. Davey Smith G, Shipley M, Leon DA. Height and mortality from cancer among men: Prospective observational study. BMJ 1998;317:1351-1352.
34. Albanes D. Height, early energy intake, and cancer: Evidence mounts for the relation of energy intake to adult malignancies. BMJ 1998;317:1331-1332.
35. Andersson SO, Wolk A, Bergström R, Adami HO, Engholm G, Englund A, Nyrén O. Body size and prostate cancer: A 20-year follow-up study among 135006 Swedish construction workers. J Natl Cancer Inst 1997;89:385-389.
36. Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Willett WC. Height, body weight, and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 1997;6:557-563.
37. Hebert PR, Ajani U, Cook NR, Lee IM, Chan KS, Hennekens CH. Adult height and incidence of cancer in male physicians (United States). Cancer Causes Control 1997;8:591-597.
38. Gunnell DJ, Davey Smith G, Holly JMP, Frankel S. Leg length and risk of cancer in the Boyd Orr cohort. BMJ 1998;317:1350-1351.
39. Nilsen TI, Vatten LJ. Anthropometry and prostate cancer risk: A prospective study of 22,248 Norwegian men. Cancer Causes Control 1999;10:269-275.
40. Norrish AE, McRae CU, Holdaway IM, Jackson RT. Height-related risk factors for prostate cancer. Br J Cancer 2000;82:241-245.
41. Giles GG, Severi G, English DR, McCredie MRE, MacInnis R, Boyle P, Hopper JL. Early growth, adult body size and prostate cancer risk. Int J Cancer 2003;103:241-245.
42. Leon DA, Koupilova I, Lithell HO, Berglund L, Mohsen R, Vågerö D, Lithell UB, McKeigue PM. Failure to realise growth potential in utero and adult obesity in relation to blood pressure in 50 year old Swedish men. BMJ 1996;312:401-406.
43. Lithell HO, McKeigue PM, Berglund L, Mohsen R, Lithell UB, Leon DA. Relation of size at birth to non-insulin dependent diabetes and insulin concentrations in men aged 50-60 years. BMJ 1996;312:406-410.
44. Ekbom A, Hsieh C-C, Lipworth L, Wolk A, Pontén J, Adami HO, Trichopoulos D. Perinatal characteristics in relation to incidence of and mortality from prostate cancer. BMJ 1996;313:337-341.
45. Platz EA, Giovannucci E, Rimm EB, Curhan GC, Spiegelman D, Colditz GA, Willett WC. Retrospective analysis of birth weight and prostate cancer in health professionals follow-up study. Am J Epidemiol 1998;147:1140-1144.
46. Ekbom A, Wuu J, Adami HO, Lu CM, Lagiou P, Trichopoulos D, Hsieh CC. Duration of gestation and prostate cancer risk in offspring - Short communication. Cancer Epidemiol Biomarkers Prev 2000;9:221-223.
47. Boland LL, Mink PJ, Bushhouse SA, Folsom AR. Weight and length at birth and risk of early-onset prostate cancer (United States). Cancer Causes Control 2003;14(4):335-338.
48. Kajantie E, Osmond C, Barker DJP, Forsén T, Phillips DIW, Eriksson JG. Size at birth as a predictor of mortality in adulthood: A follow-up of 350 000 person-years. Int J Epidemiol 2005;34:655-663.
49. Welin L, Svärdsudd K, Ander-Peciva S, Tibblin G, Tibblin B, Larsson B. Prospective study of social influences on mortality: The Study of Men Born in 1913 and 1923. Lancet 1985;i:915-918.
50. Eriksson M, Cnattingius S, Svärdsudd K, Tibblin G. Factors associated with birth weight in Sweden: The study of men born in 1913. J Epidemiol Community Health 1997;51:19-23.
51. Eriksson M, Wallander M-A, Krakau I, Wedel H, Svärdsudd K. Birth weight and cardiovascular risk factors in a cohort followed until 80 years of aged: The Study of Men Born in 1913. J Internal Med 2004;255:236-246.
52. Eriksson M, Wallander M-A, Krakau I, Wedel H, Svärdsudd K. Impact of birth weight on coronary heart disease morbidity and mortality in a birth cohort followed up for 85 years: A population-based study of men born in 1913. J Intern Med 2004;256:472-481.
53. Eriksson M, Åkerman S. Geografisk och social rörlighet (Geographic and social mobility). Scandia 1974;40:260-310.
54. SAS Institute Inc. SAS Version 6.12. Cary, NC, USA: SAS Institute Inc., 1989-1996.
55. SAS Institute Inc. JMP Version 3.1.5. Cary, NC, USA: SAS Institute Inc., 1995.
56. The National Board of Health and Welfare. Cancer incidence of Sweden 2002. Stockholm 2003.
57. Törnblom M, Eriksson H, Franzén S, Gustafsson O, Lilja H, Norming U, Hugosson J. Lead time associated with screening for prostate cancer. Int J Cancer 2004;108:122-129.
58. Okasha M, Gunnell D, Holly J, Davey Smith G. Childhood growth and adult cancer. Best Pract Res Clin Endocrinol Metab 2002;16:225-241.